Patents Assigned to Ascensia Diabetes Care Holdings AG
-
Patent number: 11672451Abstract: A lancing device has a domed structure that can be depressed by application of a force by a user's finger so as to expose the tip of a needle. The domed structure is configured to move from a non-depressed state to a depressed state in a manner that allows for the piercing of the user's finger. The domed structure may then recoil to its original, non-depressed position upon the user ceasing to apply the force. Other embodiments of a lancing device are disclosed.Type: GrantFiled: April 10, 2020Date of Patent: June 13, 2023Assignee: Ascensia Diabetes Care Holdings AGInventors: Eugene Prais, Robert S. Sams, Simin Yao
-
Patent number: 11677254Abstract: A battery-operated electronic device, such as, e.g., a continuous glucose monitoring (CGM) transmitter, has a switch disconnect circuit that reduces battery discharge while the device is stored and/or in “shelf mode.” The device has two externally-accessible activation pads each configured to contact a same electrical conductor positioned in packaging for the device that causes the switch disconnect circuit to disconnect the battery from device electronics while the device is in the packaging. Upon removal of the device from the packaging, the two activation pads no longer contact the electrical conductor, causing the switch disconnect circuit to automatically connect the battery to the device electronics. Methods of reducing battery discharge in a battery-operated electronic device and other aspects are also described.Type: GrantFiled: September 17, 2020Date of Patent: June 13, 2023Assignee: Ascensia Diabetes Care Holdings AGInventor: Igor Y. Gofman
-
Patent number: 11666253Abstract: Continuous glucose monitoring (CGM) may include applying a periodic excitation signal via an electrode of a CGM sensor to human interstitial fluid to drive an oxidation/reduction reaction, and measuring the current through the electrode. In some embodiments, the measured current is sampled and digitized, and various harmonics of the excitation signal's fundamental frequency are extracted. A set of relationships of at least two harmonics each is generated from the spectral amplitudes of a set of pairs, triplets, etc., of the harmonics, and the set of relationships is mapped to a glucose concentration such as based on the contents of a harmonic relationship database having a pre-existing set of harmonic relationships and glucose concentrations to which those sets of harmonic relationships correspond, for example. Numerous other embodiments are provided.Type: GrantFiled: February 20, 2020Date of Patent: June 6, 2023Assignee: Ascensia Diabetes Care Holdings AGInventors: Juergen J. Zach, Daniel V. Brown
-
Patent number: 11644434Abstract: Methods and biosensor systems for compensating an analyte measurement are provided. The methods and systems determine a secondary output signal based on the measured primary output signal in order to better approximate the effects of an extraneous stimulus on the primary output signal under actual measurement conditions. The methods and systems according to the present disclosure may provide a more accurate analyte measurement, and may be particularly useful in detecting and compensating an analyte measurement during an off-condition.Type: GrantFiled: May 13, 2016Date of Patent: May 9, 2023Assignee: Ascensia Diabetes Care Holdings AGInventor: Huan-Ping Wu
-
Patent number: 11638542Abstract: Continuous glucose monitoring (CGM) may include applying a periodic excitation signal via an electrode of a CGM sensor to human interstitial fluid to drive an oxidation/reduction reaction, and measuring the current through the electrode. In some embodiments, the measured current is sampled and digitized, and various harmonics of the excitation signal's fundamental frequency are extracted. A set of relationships of at least two harmonics each is generated from the spectral amplitudes of a set of pairs, triplets, etc., of the harmonics, and the set of relationships is mapped to a glucose concentration such as based on the contents of a harmonic relationship database having a pre-existing set of harmonic relationships and glucose concentrations to which those sets of harmonic relationships correspond, for example. Numerous other embodiments are provided.Type: GrantFiled: February 20, 2020Date of Patent: May 2, 2023Assignee: Ascensia Diabetes Care Holdings AGInventors: Juergen J. Zach, Daniel V. Brown
-
Patent number: 11602373Abstract: A biosensor inserter includes a push member with a push element, a contact member including a latch, a transmitter carrier supporting a transmitter and sensor assembly, and a pivot member having a latch end, the pivot member supporting an insertion device during biosensor insertion. In operation, the push member is telescoped axially by the user relative to the contact member, which is provided in contact with a user's skin. This pushes the push element against the pivot member and translates the transmitter carrier during insertion of the biosensor. During a first portion of a stroke of the insertion device, insertion of the biosensor is accomplished, and the pivot member is prevented from pivoting. In a second portion of the stroke, after latch end moves past the latch, the pivot member is allowed to pivot and the insertion device is retracted. Other system and method embodiments are provided.Type: GrantFiled: August 3, 2020Date of Patent: March 14, 2023Assignee: Ascensia Diabetes Care Holdings AGInventors: Nicholas Erekovcanski, Eugene R. Prais, Thomas A. J. Mayer, Jr., Cameron M. Young
-
Patent number: 11598763Abstract: A system for measuring health data includes a measurement device. The measurement device includes at least one measurement interface to receive a first fluid sample, a processor to measure one or more first characteristics of the first fluid sample, and at least one memory device to store first data. The processor reads the first data and measures the one or more first characteristics of the first fluid sample according to the first data. The at least one memory device also stores second data. The processor reads the second data instead of the first data to reconfigure the measurement device and measures one or more second characteristics of a second fluid sample according to the second data. An external processing device may be communicatively coupled to the measurement device and may execute a healthcare application that communicates with the measurement device and may be employed to reconfigure the measurement device.Type: GrantFiled: August 4, 2015Date of Patent: March 7, 2023Assignee: Ascensia Diabetes Care Holdings AGInventors: Jun Chen, Christopher A. Dionisio
-
Patent number: 11584945Abstract: A biosensor system, method and apparatus are provided for implementing threshold based correction functions for biosensors. A primary measurement of an analyte value is obtained. A secondary measurement of a secondary effect is obtained and is compared with a threshold value. A correction function is identified responsive to the compared values. The correction function is applied to the primary measurement of the analyte value to provide a corrected analyte value. The correction method uses correction curves that are provided to correct for an interference effect. The correction curves can be linear or non-linear. The correction method provides different correction functions above and below the threshold value. The correction functions may be dependent or independent of the primary measurement that is being corrected. The correction functions may be either linear or nonlinear.Type: GrantFiled: December 17, 2018Date of Patent: February 21, 2023Assignee: Ascensia Diabetes Care Holdings AGInventor: George A. Mecklenburg
-
Patent number: 11547330Abstract: Apparatus and methods are operative to probe the condition of a sensor either initially, at any point thereafter or continuously during a continuous sensor operation for measuring an analyte in a bodily fluid (such as performed by, e.g., a continuous glucose monitoring (CGM) sensor). Results of the probe may include calibration indices determined from electrical signals obtained during the probe. The calibration indices may indicate whether in-situ adjustment of the sensor's calibration should be performed either initially and/or at random check points. Probing potential modulation parameters also may be used during analyte calculations to reduce the effects of lot-to-lot sensitivity variations, sensitivity drift during monitoring, temperature, interferents, and/or the like. Other aspects are disclosed.Type: GrantFiled: February 5, 2020Date of Patent: January 10, 2023Assignee: Ascensia Diabetes Care Holdings AGInventor: Huan-Ping Wu
-
Patent number: 11532392Abstract: A method for using a meter and a meter (10) adapted to determine an analyte concentration reading, the meter comprising a display (12) adapted to display information to a user of the meter, the display including information directed to a post-meal test-time alarm (22?) that is adapted to remind the user to obtain a post-meal analyte concentration reading, and at least one user input mechanism (15) adapted to allow the user to activate the post-meal test-time alarm.Type: GrantFiled: December 22, 2020Date of Patent: December 20, 2022Assignee: Ascensia Diabetes Care Holdings AGInventors: Barry D. Power, Jeffrey A. Culver
-
Patent number: 11520890Abstract: A medical device includes at least one memory device storing data; a communication interface defining a first communication path to allow communications between the medical device and an external device or network; and a hardware key interface defining a second communication path that is separate from the first communication path. A hardware key is configured to be coupled to the meter via the second communication path defined by the hardware key interface. The data on the at least one memory device cannot be modified unless the hardware key interface is physically coupled to the hardware key. The hardware key may include a key code component and conducting lines, where the hardware key interface receives the key code via the conducting lines and the data on the at least one memory device cannot be modified unless the key code provided by the hardware key is validated.Type: GrantFiled: October 23, 2014Date of Patent: December 6, 2022Assignee: Ascensia Diabetes Care Holdings AGInventor: Jeffery S. Reynolds
-
Patent number: 11499960Abstract: A test sensor for determining an analyte concertation in a biological fluid comprises a strip including a fluid receiving area and port-insertion region. A first row of optically transparent and non-transparent positions forms a calibration code pattern disposed within a first area of the port-insertion region. A second row of optically transparent and non-transparent positions forms a synchronization code pattern disposed within a second area of the port-insertion region. The second area is different from the first area. The synchronization code pattern corresponds to the calibration code pattern such that the synchronization code pattern provides synchronization of the serial calibration code pattern during insertion of the port-insertion region into the receiving port of the analyte meter.Type: GrantFiled: January 27, 2021Date of Patent: November 15, 2022Assignee: Ascensia Diabetes Care Holdings AGInventor: Igor Gofman
-
Patent number: 11445944Abstract: Continuous glucose monitoring (CGM) may include applying a periodic excitation signal via an electrode of a CGM sensor to human interstitial fluid to drive an oxidation/reduction reaction, and measuring the current through the electrode. In some embodiments, the measured current is sampled and digitized, and various harmonics of the excitation signal's fundamental frequency are extracted. A set of relationships of at least two harmonics each is generated from the spectral amplitudes of a set of pairs, triplets, etc., of the harmonics, and the set of relationships is mapped to a glucose concentration such as based on the contents of a harmonic relationship database having a pre-existing set of harmonic relationships and glucose concentrations to which those sets of harmonic relationships correspond, for example. Numerous other embodiments are provided.Type: GrantFiled: February 20, 2020Date of Patent: September 20, 2022Assignee: Ascensia Diabetes Care Holdings AGInventors: Juergen J. Zach, Daniel V. Brown
-
Patent number: 11450411Abstract: A testing system and method for providing a testing system includes a user interface having a display for displaying information relating to measurements of health data and an input device for receiving information from a user relating to the health data. Provided in connection with the user interface is an autologging feature adapted to provide the user with user-selectable options on the display. Also provided is a statistical operation adapted to provide the user with enhanced information relating to the measurements of health data. Also provided is at least one indicator for indicating information relating to the number of health data readings that are within a target range, the number of health data readings that are above the target range and the number of health data readings that are below the target range.Type: GrantFiled: January 17, 2020Date of Patent: September 20, 2022Assignee: Ascensia Diabetes Care Holdings AGInventors: Jacob Brauer, Darren Brown, Jun Chen, Richard Kates, Jennifer M. Levin, Harris Lieber, Amy Schwartz, Raymond Yao
-
Patent number: 11442035Abstract: A method of depositing reagent on an electrochemical test sensor adapted to determine information relating to an analyte includes providing a base and forming an electrode pattern on the base. The method further includes depositing the reagent on at least the electrode pattern using a reagent-dispensing system. The reagent-dispensing system applies mechanical force to the reagent in the reagent-dispensing system to assist in providing a wet reagent droplet on at least the electrode pattern.Type: GrantFiled: November 1, 2017Date of Patent: September 13, 2022Assignee: Ascensia Diabetes Care Holdings AGInventors: Boru Zhu, Herbert Henley, Jr.
-
Patent number: 11435312Abstract: A sensor system, device, and methods for determining the concentration of an analyte in a sample is described. Gated voltammetric pulse sequences including multiple duty cycles of sequential excitations and relaxations may provide a shorter analysis time and/or improve the accuracy and/or precision of the analysis. The disclosed pulse sequences may reduce analysis errors arising from the hematocrit effect, variance in cap-gap volumes, non-steady-state conditions, mediator background, a single set of calibration constants, under-fill, and changes in the active ionizing agent content of the sensor strip.Type: GrantFiled: May 4, 2020Date of Patent: September 6, 2022Assignee: Ascensia Diabetes Care Holdings AGInventor: Huan-Ping Wu
-
Patent number: 11399269Abstract: Some embodiments of the present invention include pairing two wireless devices by placing at least one of two devices in a pairing mode; performing at least one pairing motion event with at least one of the wireless devices to satisfy at least one pairing condition; detecting satisfaction of the at least one pairing condition; and pairing the two wireless devices in response to detecting satisfaction of the at least one pairing condition. Numerous other aspects are provided.Type: GrantFiled: February 3, 2020Date of Patent: July 26, 2022Assignee: Ascensia Diabetes Care Holdings AGInventors: Qiang Fu, Alexander Markovic, Joseph R. Anstett, Jr., Vladislav Milenkovic
-
Patent number: 11391721Abstract: The cartridge comprises a housing, a plurality of test sensors, a mechanical mechanism, and a pusher assembly. The housing forms at least one opening therethrough. The plurality of test sensors is stacked in the housing. The plurality of test sensors is adapted to assist in testing at least one analyte. The mechanical mechanism is adapted to urge the plurality of test sensors in a first direction. One of the plurality of test sensors is positioned for extraction from the cartridge. The pusher assembly is adapted to push one of the plurality of test sensors from the cartridge. The pusher assembly includes a ferromagnetic material or a magnet.Type: GrantFiled: October 28, 2020Date of Patent: July 19, 2022Assignee: Ascensia Diabetes Care Holdings AGInventors: Jeffery S. Reynolds, John P. Creaven
-
Patent number: 11361863Abstract: Embodiments provide systems, methods and apparatus for diabetes management using location-based reminders. Embodiments include requesting a user select a diabetes management related task to be reminded to perform; requesting the user select a location at which the user is to be reminded to perform the selected diabetes management related task; monitoring the user's location; detecting the user has entered the selected location; triggering the reminder in response to detecting the user has entered the selected location; and presenting the reminder to the user. Numerous other aspects are provided like helping a user locate a blood glucose meter (BGM) by identifying a most recent data transfer from the BGM based on a stored date and time associated with the most recent data transfer from the BGM, and identifying patterns of diabetes management events corresponding to particular location types.Type: GrantFiled: April 29, 2016Date of Patent: June 14, 2022Assignee: Ascensia Diabetes Care Holdings AGInventors: Jennifer L. Gass, Michael Harboun, Simon King
-
Patent number: D985774Type: GrantFiled: March 30, 2021Date of Patent: May 9, 2023Assignee: Ascensia Diabetes Care Holdings AGInventors: Dragan Avirovikj, Jon Taylor